Hypodermic Needles Market: Segmented: By Products (Safety Hypodermic Needles, Non-safety Hypodermic Needles), By Application (Drug Delivery, Vaccination, Blood Specimen Collection), By End Users (Hospital, Diabetic Patients, Family Practitioners, Psychiatry, Others), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
[ 170 + Pages Research Report ] Hypodermic Needles Market to surpass USD 5 billion by 2031 from USD 2.9 billion in 2021 at a CAGR of 5.4% in the coming years, i.e., 2021-2031.
Product Overview
Hypodermic needle is a hollow needle that is widely used with a syringe to inject or withdraw fluids from the body. These needles can be used to extract liquid samples from the body, such as blood from a vein during venipuncture. Large-bore hypodermic intervention is particularly beneficial in the treatment of severe blood loss or shock. A hypodermic needle also allows liquids to be delivered quickly. It's also employed when the injected chemical can't be taken orally because it wouldn't be absorbed (like insulin) or would injure the liver.
Market Highlights
Global Hypodermic Needles Market is expected to project a notable CAGR of 5.4% in 2031.
Growing occurrences of chronic and lifestyle diseases, particularly an increase in diabetes prevalence globally, technical developments in the hypodermic needles market, and increased demand for sophisticated hypodermic needle solutions are projected to boost market expansion. The rise in disposable incomes, as well as the possibilities for growth in emerging nations, are projected to present several chances for the hypodermic needles market projection.
Global Hypodermic Needles Market: Segments
Safety Hypodermic Needles segment is expected to witness the highest CAGR during 2021-31
On the basis of Product, the global Hypodermic Needles Market is fragmented into Safety Hypodermic Needles, Non-safety Hypodermic Needles. Owing to the developments in R&D activities in the healthcare sector and an increase in the occurrence of needlestick injuries, the safety hypodermic needles segment dominated the market in 2020, and this trend is projected to continue over the forecast period. Owing to the ease and safety that these goods provide, safety hypodermic needles are widely chosen over non-safety hypodermic needles. Luer lock, single-handed technique, and other safety features are included in safety hypodermic needles.
Hospital segment is expected to grow with the highest CAGR during 2021-31
Global Hypodermic Needles Market is classified on the basis of End Users into Hospital, Diabetic Patients, Family Practitioners, Psychiatry, and Others. In 2020, hospitals were the most common consumers of hypodermic needles, and this trend is likely to continue throughout the projection period. Hypodermic needles are commonly used in hospitals for a variety of purposes, including immunization, medicine delivery, blood specimen collection, and more. In addition, hospitals in wealthy countries have made the use of hypodermic needles mandatory.
Market Dynamics
Drivers
Growing prevalence of chronic disorders and improvements in hypodermic needle-based drug delivery
The global hypodermic needles market is being driven by the rising prevalence of chronic diseases and technical developments in hypodermic needle-based drug delivery. Many industrial companies invest in Asia because of the lower wages and greater availability of skilled workers. In addition, as people become more aware of numerous chronic conditions, the market for hypodermic needles is growing in developing countries.
Rising technological advancements to manufacture hypodermic needles
During the projected period, technological advancements in the pharmaceutical industry to manufacture safe hypodermic needles are expected to create lucrative chances for expanding the worldwide hypodermic needles market size. Furthermore, the existence of important manufacturing businesses that produce and distribute hypodermic needles, as well as an increase in healthcare spending, are driving the growth of the hypodermic needles market.
Restraint
Easy availability of substitute modes of drug delivery and significantly priced needles
The availability of alternate ways of drug delivery, a lack of information about safety syringes, and the expensive cost of hypodermic needles all impede the market's growth.
Global Hypodermic Needles Market: Key Players
Becton, Dickinson and Company
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
B. Braun Melsungen Ag
Cardinal Health Inc.
Connecticut Hypodermics Inc.
Exelint International Co.
Mckesson Corporation
Hitech Syringes
Retractable Technologies, Inc.
Nipro Corporation
Terumo Medical Corporation
Other Prominent Players
Global Hypodermic Needles Market: Regions
Global Hypodermic Needles Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Owing to increase in the prevalence of chronic diseases, a large population base (with China and India being the most populated countries), unmet medical needs, rising disposable incomes, and increased awareness about the use of hypodermic needles in the region, Asia-Pacific dominated the hypodermic needles market in 2020 and is expected to continue to do so during the forecast period.
Impact of COVID-19 on Hypodermic Needles Market
The market for hypodermic needles exploded after COVID-19 for a variety of reasons, including the demand for both safety and non-safety hypodermic needles. The COVID-19 outbreak is projected to increase demand for both safety and non-safety hypodermic needles as a result of the outbreak. As a result, the growth in demand for more productive and cost-effective needles is predicted to strengthen the industrial component of the hypodermic needles market, as well as the engineering potential, thanks to increased investment from key stakeholders and investors.
Global Hypodermic Needles Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States, Mexico, and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Australia, and Rest of Asia Pacific
The Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Saudi Arabia, South Africa, and Rest of the Middle East and Africa
The Global Hypodermic Needles Market report also contains analysis on:
Hypodermic Needles Market Segments:
By Product
Safety Hypodermic Needles
Non-safety Hypodermic Needles
By Application
Drug Delivery
Vaccination
Blood Specimen Collection
By End Users
Hospital
Diabetic Patients
Family Practitioners
Psychiatry
Others
Hypodermic Needles Market Dynamics
Hypodermic Needles Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Hypodermic Needles Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 2.9 billion
Revenue forecast in 2031 USD 5 billion
Growth Rate CAGR of 5.4% from 2021 to 2031
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, Application, End Users, and Region
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hitech Syringes, Retractable Technologies, Inc., Nipro Corporation, Terumo Medical Corporation, and Other Prominent Players.
Product Overview
Hypodermic needle is a hollow needle that is widely used with a syringe to inject or withdraw fluids from the body. These needles can be used to extract liquid samples from the body, such as blood from a vein during venipuncture. Large-bore hypodermic intervention is particularly beneficial in the treatment of severe blood loss or shock. A hypodermic needle also allows liquids to be delivered quickly. It's also employed when the injected chemical can't be taken orally because it wouldn't be absorbed (like insulin) or would injure the liver.
Market Highlights
Global Hypodermic Needles Market is expected to project a notable CAGR of 5.4% in 2031.
Growing occurrences of chronic and lifestyle diseases, particularly an increase in diabetes prevalence globally, technical developments in the hypodermic needles market, and increased demand for sophisticated hypodermic needle solutions are projected to boost market expansion. The rise in disposable incomes, as well as the possibilities for growth in emerging nations, are projected to present several chances for the hypodermic needles market projection.
Global Hypodermic Needles Market: Segments
Safety Hypodermic Needles segment is expected to witness the highest CAGR during 2021-31
On the basis of Product, the global Hypodermic Needles Market is fragmented into Safety Hypodermic Needles, Non-safety Hypodermic Needles. Owing to the developments in R&D activities in the healthcare sector and an increase in the occurrence of needlestick injuries, the safety hypodermic needles segment dominated the market in 2020, and this trend is projected to continue over the forecast period. Owing to the ease and safety that these goods provide, safety hypodermic needles are widely chosen over non-safety hypodermic needles. Luer lock, single-handed technique, and other safety features are included in safety hypodermic needles.
Hospital segment is expected to grow with the highest CAGR during 2021-31
Global Hypodermic Needles Market is classified on the basis of End Users into Hospital, Diabetic Patients, Family Practitioners, Psychiatry, and Others. In 2020, hospitals were the most common consumers of hypodermic needles, and this trend is likely to continue throughout the projection period. Hypodermic needles are commonly used in hospitals for a variety of purposes, including immunization, medicine delivery, blood specimen collection, and more. In addition, hospitals in wealthy countries have made the use of hypodermic needles mandatory.
Market Dynamics
Drivers
Growing prevalence of chronic disorders and improvements in hypodermic needle-based drug delivery
The global hypodermic needles market is being driven by the rising prevalence of chronic diseases and technical developments in hypodermic needle-based drug delivery. Many industrial companies invest in Asia because of the lower wages and greater availability of skilled workers. In addition, as people become more aware of numerous chronic conditions, the market for hypodermic needles is growing in developing countries.
Rising technological advancements to manufacture hypodermic needles
During the projected period, technological advancements in the pharmaceutical industry to manufacture safe hypodermic needles are expected to create lucrative chances for expanding the worldwide hypodermic needles market size. Furthermore, the existence of important manufacturing businesses that produce and distribute hypodermic needles, as well as an increase in healthcare spending, are driving the growth of the hypodermic needles market.
Restraint
Easy availability of substitute modes of drug delivery and significantly priced needles
The availability of alternate ways of drug delivery, a lack of information about safety syringes, and the expensive cost of hypodermic needles all impede the market's growth.
Global Hypodermic Needles Market: Key Players
Becton, Dickinson and Company
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
B. Braun Melsungen Ag
Cardinal Health Inc.
Connecticut Hypodermics Inc.
Exelint International Co.
Mckesson Corporation
Hitech Syringes
Retractable Technologies, Inc.
Nipro Corporation
Terumo Medical Corporation
Other Prominent Players
Global Hypodermic Needles Market: Regions
Global Hypodermic Needles Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Owing to increase in the prevalence of chronic diseases, a large population base (with China and India being the most populated countries), unmet medical needs, rising disposable incomes, and increased awareness about the use of hypodermic needles in the region, Asia-Pacific dominated the hypodermic needles market in 2020 and is expected to continue to do so during the forecast period.
Impact of COVID-19 on Hypodermic Needles Market
The market for hypodermic needles exploded after COVID-19 for a variety of reasons, including the demand for both safety and non-safety hypodermic needles. The COVID-19 outbreak is projected to increase demand for both safety and non-safety hypodermic needles as a result of the outbreak. As a result, the growth in demand for more productive and cost-effective needles is predicted to strengthen the industrial component of the hypodermic needles market, as well as the engineering potential, thanks to increased investment from key stakeholders and investors.
Global Hypodermic Needles Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States, Mexico, and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Australia, and Rest of Asia Pacific
The Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Saudi Arabia, South Africa, and Rest of the Middle East and Africa
The Global Hypodermic Needles Market report also contains analysis on:
Hypodermic Needles Market Segments:
By Product
Safety Hypodermic Needles
Non-safety Hypodermic Needles
By Application
Drug Delivery
Vaccination
Blood Specimen Collection
By End Users
Hospital
Diabetic Patients
Family Practitioners
Psychiatry
Others
Hypodermic Needles Market Dynamics
Hypodermic Needles Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Hypodermic Needles Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 2.9 billion
Revenue forecast in 2031 USD 5 billion
Growth Rate CAGR of 5.4% from 2021 to 2031
Base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, Application, End Users, and Region
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hitech Syringes, Retractable Technologies, Inc., Nipro Corporation, Terumo Medical Corporation, and Other Prominent Players.
1. EXECUTIVE SUMMARY
2. GLOBAL HYPODERMIC NEEDLES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL HYPODERMIC NEEDLES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL HYPODERMIC NEEDLES MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. GLOBAL HYPODERMIC NEEDLES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S., Mexico, and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Australia, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Saudi Arabia, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Non-Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Drug Delivery, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Vaccination, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Blood Specimen Collection, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. End User: Market Share (2020-2031F)
12.4.1. Hospital, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Diabetic Patients, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Family Practitioners, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Psychiatry, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. COMPANY PROFILE
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. B. Braun Melsungen Ag
13.3. Cardinal Health Inc.
13.4. Connecticut Hypodermics Inc.
13.5. Exelint International Co.
13.6. Mckesson Corporation
13.7. Hitech Syringes
13.8. Retractable Technologies, Inc.
13.9. Nipro Corporation
13.10. Terumo Medical Corporation
13.11. Other Prominent Players
14. CONSULTANT RECOMMENDATION
15. THE ABOVE GIVEN SEGMENTATIONS AND COMPANIES COULD BE SUBJECTED TO FURTHER MODIFICATION BASED ON IN-DEPTH FEASIBILITY STUDIES CONDUCTED FOR THE FINAL DELIVERABLE.
2. GLOBAL HYPODERMIC NEEDLES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL HYPODERMIC NEEDLES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL HYPODERMIC NEEDLES MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. GLOBAL HYPODERMIC NEEDLES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S., Mexico, and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Australia, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Saudi Arabia, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Non-Safety Hypodermic Needles, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Drug Delivery, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Vaccination, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Blood Specimen Collection, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. End User: Market Share (2020-2031F)
12.4.1. Hospital, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Diabetic Patients, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Family Practitioners, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Psychiatry, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.5. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. COMPANY PROFILE
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. B. Braun Melsungen Ag
13.3. Cardinal Health Inc.
13.4. Connecticut Hypodermics Inc.
13.5. Exelint International Co.
13.6. Mckesson Corporation
13.7. Hitech Syringes
13.8. Retractable Technologies, Inc.
13.9. Nipro Corporation
13.10. Terumo Medical Corporation
13.11. Other Prominent Players
14. CONSULTANT RECOMMENDATION
15. THE ABOVE GIVEN SEGMENTATIONS AND COMPANIES COULD BE SUBJECTED TO FURTHER MODIFICATION BASED ON IN-DEPTH FEASIBILITY STUDIES CONDUCTED FOR THE FINAL DELIVERABLE.
